Navigating the Shift from Opioids to Non-Pharmacologic Treatments in Workers' Compensation

Navigating the Shift from Opioids to Non-Pharmacologic Treatments in Workers' Compensation

The Decline in Opioid Prescribing for Injured Workers

As the opioid epidemic continues to roil the country, it’s easy to forget the number of issues that contribute to its severity. Indeed, for workers injured on the job, compensation can include opioid treatments—which can lead to opioid dependence. With this subject in mind, I spoke to Dr. Vennela Thumula, an author and policy analyst with the Workers Compensation Research Institute (WCRI), who was able to provide insight into opioid dispensing for injured workers.

Insurance Image

States with Higher-than-Average Prescribing Rates

After the declines, opioid dispensing continues to be prevalent in some states. At the end of the study period, the percentage of injured workers with prescriptions receiving opioids ranged from 32 percent in New Jersey to 70 percent in Arkansas and Louisiana across the 27 states, and the average MME per worker in Delaware, Louisiana, Pennsylvania, and New York continued to be the highest among the 27 study states.

Insurance Image

The Rise of Non-Pharmacologic Treatments

We see that providers have switched from multi-pronged pain treatments, which involve pain medications (including opioids) and other restorative therapies, to a treatment protocol that more frequently relies solely on non-pharmacologic services. The most frequent non-pharmacologic services billed and paid under workers compensation were physical medicine evaluation; active and passive physical medicine services such as electrical stimulation and hot and cold therapies; and passive manipulations such as manual therapy and massage.

Insurance Image

Our first look at the data suggests a shift in treatment patterns away from opioids to non-pharmacologic services, which conforms to the recommendations of opioid prescribing and pain treatment guidelines and policies implemented in a number of states. Many questions remain answered, including the impact of these changing treatment patterns on claim outcomes. We will be talking more about alternatives to opioids for pain management at WCRI’s 36 Annual Issues & Research Conference, March 5 and 6, 2020, in Boston, MA.

 

In conclusion, while the shift from opioids to non-pharmacologic treatments is promising, it is crucial for both patients and insurance companies to stay informed about the latest research and guidelines. Engaging in regular discussions with healthcare providers and attending conferences like WCRI’s can provide valuable insights and help in making informed decisions about pain management strategies.